ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,665Medicare Part D Prescriptions Filled, Including Refills

Rank: 79 out of 546

$400K Total Retail Price of All Prescriptions

Rank: 97 out of 546

374 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 374 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

17% of this provider’s 374 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 4,045 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
HYDROCODONE-ACETAMINOPHEN 274 111 S3 1 8
SIMVASTATIN 199 117 2 2
LISINOPRIL 198 123 3 1
FUROSEMIDE 184 148 4 5
OMEPRAZOLE 175 98 5 4
LEVOTHYROXINE SODIUM 158 124 6 3
OXYCODONE HCL 152 28 S2 7 15
PANTOPRAZOLE SODIUM 151 76 8 18
SERTRALINE HCL 149 107 9 14
MELOXICAM 127 68 10 58
AMLODIPINE BESYLATE 118 91 11 9
HYDROCHLOROTHIAZIDE 117 86 12 7
ATORVASTATIN CALCIUM 116 96 13 11
TRAMADOL HCL 115 38 14 19
METOPROLOL TARTRATE 114 82 15 6
CITALOPRAM HBR 114 64 15 21
TAMSULOSIN HCL 99 97 17 35
CYCLOBENZAPRINE HCL 98 27 R 18 34
ZOLPIDEM TARTRATE 96 56 19 26
METOPROLOL SUCCINATE 95 66 20 17
METFORMIN HCL 91 51 21 10
POLYETHYLENE GLYCOL 3350 88 71 22 68
FENOFIBRATE 79 41 23 87
RANITIDINE HCL 78 29 24 23
LOVASTATIN 75 50 25 22
FENTANYL 73 60 S2 26 50
GLYBURIDE 73 43 R 26 45
PROAIR HFA 60 24 28 27
GABAPENTIN 58 50 29 16
FLUTICASONE PROPIONATE 55 34 30 42
JANUVIA 55 31 30 79
CYMBALTA 54 20 32 37
TRAZODONE HCL 53 25 33 25
LOSARTAN POTASSIUM 52 35 34 24
SPIRIVA 50 43 35 28
WARFARIN SODIUM 50 40 35 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.